Patents by Inventor Taek-Joo Lim

Taek-Joo Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof
    Publication number: 20240352071
    Abstract: The present invention relates to a novel peptide compound or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 27, 2024
    Publication date: October 24, 2024
    Inventors: Yoo Seok Kim, Myoung Hwan Kim, Young In Kim, Taek Joo Lim, Hyeong Joon Lim, Jee Young Kim, Eun Young Park
  • PHARMACEUTICAL COMPOSITION FOR ANIMALS CONTAINING 5-HYDROXY-METHYLIMIDAZOLIDINE-2,4-DIONE COMPOUND AS ACTIVE INGREDIENT
    Publication number: 20240299359
    Abstract: Disclosed are a pharmaceutical composition for animals containing 5-hydroxy-1-methylimidazolidine-2,4-dione as an active ingredient, more specifically, a composition for preventing or treating kidney disease in animals containing 5-hydroxy-1-methylimidazolidine-2,4-dione or a pharmaceutically acceptable salt thereof as an active ingredient, a method of treating kidney disease in animals using the compound, and a functional feed for preventing or ameliorating kidney disease in animals containing the compound as an active ingredient. The 5-hydroxy-1-methylimidazolidine-2,4-dione can effectively ameliorate and treat symptoms of kidney disease when administered to companion animals such as dogs or cats with kidney disease. Therefore, there are provided a novel agent and method for treating kidney disease of animals that can effectively treat kidney disease, which is the cause of high mortality in companion animals.
    Type: Application
    Filed: June 28, 2022
    Publication date: September 12, 2024
    Applicants: KYONGBO PHARM. CO., LTD., NDIC CO., LTD.
    Inventors: Jeong Seok HAN,, Yong Kyu PARK, Sung Hun BANG, Jae Hyun KIM, Ha Lim JANG, Ye Rin KIM, Su Kyoung LEE, Taek Joo LIM
  • Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof
    Publication number: 20240228538
    Abstract: The present invention relates to a novel peptide compound or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 20, 2020
    Publication date: July 11, 2024
    Applicant: Eyebio Korea
    Inventors: Yoo Seok Kim, Myoung Hwan Kim, Young In Kim, Taek Joo Lim, Hyeong Joon Lim, Jee Young Kim, Eun Young Park
  • Pharmaceutical composition for preventing or treating hyperlipidemia
    Patent number: 9724336
    Abstract: Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and an angiotensin II receptor blocker as active ingredients.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: August 8, 2017
    Assignee: DAEWOONG PHARMACEUTICAL CO., LTD.
    Inventors: Jong-Wook Lee, Sang-Ho Lee, Taek-Joo Lim, Eun-Ji Koh
  • Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
    Patent number: 9486443
    Abstract: The present invention is a method for treating hyperlipidemia comprising (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt and amlodipine or its pharmaceutically acceptable salt at a synergistic ratio of about 4:1.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: November 8, 2016
    Assignee: DAEWOONG PHARMACEUTICAL CO., LTD.
    Inventors: Jong-Wook Lee, Sang-Ho Lee, Taek-Joo Lim, Eun-Ji Koh
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERTRIGLYCERIDEMIA OR HYPERTRIGLYCERIDEMIA-ASSOCIATED DISEASES
    Publication number: 20140336228
    Abstract: Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and a calcium channel blocker or a fibrate as active ingredients.
    Type: Application
    Filed: November 28, 2012
    Publication date: November 13, 2014
    Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.
    Inventors: Jong-Wook Lee, Sang-Ho Lee, Taek-Joo Lim, Eun-Ji Koh
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA
    Publication number: 20140336229
    Abstract: Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and an angiotensin II receptor blocker as active ingredients.
    Type: Application
    Filed: November 28, 2012
    Publication date: November 13, 2014
    Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.
    Inventors: Jong-Wook Lee, Sang-Ho Lee, Taek-Joo Lim, Eun-Ji Koh